173 related articles for article (PubMed ID: 18066804)
1. Solid-phase synthesis of modified RNAs containing amide-linked oligoribonucleosides at their 3'-end and their application to siRNA.
Iwase R; Toyama T; Nishimori K
Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1451-4. PubMed ID: 18066804
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and properties of modified siRNA having amide-linked oligoribonucleosides at their 3' overhang regions.
Iwase R; Miyao H; Toyama T; Nishimori K
Nucleic Acids Symp Ser (Oxf); 2006; (50):175-6. PubMed ID: 17150874
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of modified double stranded RNAs containing duplex regions between amide-linked RNA and RNA at both ends and enhanced nuclease resistance.
Iwase R; Kurokawa R; Ueno J
Nucleic Acids Symp Ser (Oxf); 2009; (53):119-20. PubMed ID: 19749289
[TBL] [Abstract][Full Text] [Related]
4. RNA interference induced by siRNAs modified with 4'-thioribonucleosides.
Hoshika S; Minakawa N; Matsuda A
Nucleic Acids Symp Ser (Oxf); 2005; (49):77-8. PubMed ID: 17150641
[TBL] [Abstract][Full Text] [Related]
5. Palmitic acid-conjugated 21-nucleotide siRNA enhances gene-silencing activity.
Kubo T; Yanagihara K; Takei Y; Mihara K; Morita Y; Seyama T
Mol Pharm; 2011 Dec; 8(6):2193-203. PubMed ID: 21985606
[TBL] [Abstract][Full Text] [Related]
6. Design of nuclease-resistant fork-like small interfering RNA (fsiRNA).
Chernolovskaya EL; Zenkova MA
Methods Mol Biol; 2013; 942():153-68. PubMed ID: 23027050
[TBL] [Abstract][Full Text] [Related]
7. Improving RNA interference in mammalian cells by 4'-thio-modified small interfering RNA (siRNA): effect on siRNA activity and nuclease stability when used in combination with 2'-O-alkyl modifications.
Dande P; Prakash TP; Sioufi N; Gaus H; Jarres R; Berdeja A; Swayze EE; Griffey RH; Bhat B
J Med Chem; 2006 Mar; 49(5):1624-34. PubMed ID: 16509579
[TBL] [Abstract][Full Text] [Related]
8. SiRNAs conjugated with aromatic compounds induce RISC-mediated antisense strand selection and strong gene-silencing activity.
Kubo T; Yanagihara K; Takei Y; Mihara K; Sato Y; Seyama T
Biochem Biophys Res Commun; 2012 Oct; 426(4):571-7. PubMed ID: 22982308
[TBL] [Abstract][Full Text] [Related]
9. Gene-silencing properties of siRNAs that contain internal amide-bond linkages.
Gong W; Desaulniers JP
Bioorg Med Chem Lett; 2012 Nov; 22(22):6934-7. PubMed ID: 23062704
[TBL] [Abstract][Full Text] [Related]
10. Study of modification pattern-RNAi activity relationships by using siRNAs modified with 4'-thioribonucleosides.
Hoshika S; Minakawa N; Shionoya A; Imada K; Ogawa N; Matsuda A
Chembiochem; 2007 Nov; 8(17):2133-8. PubMed ID: 17924376
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of nuclease-resistant siRNAs possessing universal overhangs.
Ueno Y; Watanabe Y; Shibata A; Yoshikawa K; Takano T; Kohara M; Kitade Y
Bioorg Med Chem; 2009 Mar; 17(5):1974-81. PubMed ID: 19200743
[TBL] [Abstract][Full Text] [Related]
12. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.
Bartlett DW; Davis ME
Biotechnol Bioeng; 2007 Jul; 97(4):909-21. PubMed ID: 17154307
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological properties of chemically modified siRNAs bearing 1-deoxy-D-ribofuranose in their 3'-overhang region.
Taniho K; Nakashima R; Kandeel M; Kitamura Y; Kitade Y
Bioorg Med Chem Lett; 2012 Apr; 22(7):2518-21. PubMed ID: 22377516
[TBL] [Abstract][Full Text] [Related]
14. Amide-Modified RNA: Using Protein Backbone to Modulate Function of Short Interfering RNAs.
Kotikam V; Rozners E
Acc Chem Res; 2020 Sep; 53(9):1782-1790. PubMed ID: 32658452
[TBL] [Abstract][Full Text] [Related]
15. RNA interference induced by siRNAs modified with 4'-thioribonucleosides in cultured mammalian cells.
Hoshika S; Minakawa N; Kamiya H; Harashima H; Matsuda A
FEBS Lett; 2005 Jun; 579(14):3115-8. PubMed ID: 15919084
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, gene silencing, and molecular modeling studies of 4'-C-aminomethyl-2'-O-methyl modified small interfering RNAs.
Gore KR; Nawale GN; Harikrishna S; Chittoor VG; Pandey SK; Höbartner C; Patankar S; Pradeepkumar PI
J Org Chem; 2012 Apr; 77(7):3233-45. PubMed ID: 22372696
[TBL] [Abstract][Full Text] [Related]
17. Structural and binding study of modified siRNAs with the Argonaute 2 PAZ domain by NMR spectroscopy.
Maiti M; Nauwelaerts K; Lescrinier E; Herdewijn P
Chemistry; 2011 Feb; 17(5):1519-28. PubMed ID: 21268154
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, RNAi activity and nuclease-resistant properties of apolar carbohydrates siRNA conjugates.
Vengut-Climent E; Terrazas M; Lucas R; Arévalo-Ruiz M; Eritja R; Morales JC
Bioorg Med Chem Lett; 2013 Jul; 23(14):4048-51. PubMed ID: 23764303
[TBL] [Abstract][Full Text] [Related]
19. Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication.
Morrissey DV; Blanchard K; Shaw L; Jensen K; Lockridge JA; Dickinson B; McSwiggen JA; Vargeese C; Bowman K; Shaffer CS; Polisky BA; Zinnen S
Hepatology; 2005 Jun; 41(6):1349-56. PubMed ID: 15880588
[TBL] [Abstract][Full Text] [Related]
20. The design, selection, and evaluation of highly specific and functional siRNA incorporating unlocked nucleobase analogs.
Vaish N; Agarwal P
Methods Mol Biol; 2013; 942():111-34. PubMed ID: 23027048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
